These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 34954891)

  • 1. EHMT1/EHMT2 in EMT, cancer stemness and drug resistance: emerging evidence and mechanisms.
    Nachiyappan A; Gupta N; Taneja R
    FEBS J; 2022 Mar; 289(5):1329-1351. PubMed ID: 34954891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histone methyltransferases EHMT1 and EHMT2 (GLP/G9A) maintain PARP inhibitor resistance in high-grade serous ovarian carcinoma.
    Watson ZL; Yamamoto TM; McMellen A; Kim H; Hughes CJ; Wheeler LJ; Post MD; Behbakht K; Bitler BG
    Clin Epigenetics; 2019 Nov; 11(1):165. PubMed ID: 31775874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. G9a is essential for EMT-mediated metastasis and maintenance of cancer stem cell-like characters in head and neck squamous cell carcinoma.
    Liu S; Ye D; Guo W; Yu W; He Y; Hu J; Wang Y; Zhang L; Liao Y; Song H; Zhong S; Xu D; Yin H; Sun B; Wang X; Liu J; Wu Y; Zhou BP; Zhang Z; Deng J
    Oncotarget; 2015 Mar; 6(9):6887-901. PubMed ID: 25749385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. G9a interacts with Snail and is critical for Snail-mediated E-cadherin repression in human breast cancer.
    Dong C; Wu Y; Yao J; Wang Y; Yu Y; Rychahou PG; Evers BM; Zhou BP
    J Clin Invest; 2012 Apr; 122(4):1469-86. PubMed ID: 22406531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alternative splicing modulates cancer aggressiveness: role in EMT/metastasis and chemoresistance.
    Roy Burman D; Das S; Das C; Bhattacharya R
    Mol Biol Rep; 2021 Jan; 48(1):897-914. PubMed ID: 33400075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histone methyltransferase G9a and H3K9 dimethylation inhibit the self-renewal of glioma cancer stem cells.
    Tao H; Li H; Su Y; Feng D; Wang X; Zhang C; Ma H; Hu Q
    Mol Cell Biochem; 2014 Sep; 394(1-2):23-30. PubMed ID: 24833465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting EHMT2/ G9a for cancer therapy: Progress and perspective.
    Jan S; Dar MI; Wani R; Sandey J; Mushtaq I; Lateef S; Syed SH
    Eur J Pharmacol; 2021 Feb; 893():173827. PubMed ID: 33347828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of Cancer Stem Cells in Recurrent and Drug-Resistant Lung Cancer.
    Suresh R; Ali S; Ahmad A; Philip PA; Sarkar FH
    Adv Exp Med Biol; 2016; 890():57-74. PubMed ID: 26703799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone Methyltransferases G9a/
    Souza BK; Freire NH; Monteiro TS; Herlinger AL; Jaeger M; Dalmolin MGS; de Farias CB; Gregianin L; Brunetto AT; Brunetto AL; Thiele CJ; Roesler R
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging Mechanisms by which EMT Programs Control Stemness.
    Wilson MM; Weinberg RA; Lees JA; Guen VJ
    Trends Cancer; 2020 Sep; 6(9):775-780. PubMed ID: 32312682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. G9a controls pluripotent-like identity and tumor-initiating function in human colorectal cancer.
    Bergin CJ; Zouggar A; Haebe JR; Masibag AN; Desrochers FM; Reilley SY; Agrawal G; Benoit YD
    Oncogene; 2021 Feb; 40(6):1191-1202. PubMed ID: 33323965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MDC1 methylation mediated by lysine methyltransferases EHMT1 and EHMT2 regulates active ATM accumulation flanking DNA damage sites.
    Watanabe S; Iimori M; Chan DV; Hara E; Kitao H; Maehara Y
    Sci Rep; 2018 Jul; 8(1):10888. PubMed ID: 30022091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. De novo methylation of histone H3K23 by the methyltransferases EHMT1/GLP and EHMT2/G9a.
    Vinson DA; Stephens KE; O'Meally RN; Bhat S; Dancy BCR; Cole RN; Yegnasubramanian S; Taverna SD
    Epigenetics Chromatin; 2022 Nov; 15(1):36. PubMed ID: 36411491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone-lysine methyltransferase EHMT2 is involved in proliferation, apoptosis, cell invasion, and DNA methylation of human neuroblastoma cells.
    Lu Z; Tian Y; Salwen HR; Chlenski A; Godley LA; Raj JU; Yang Q
    Anticancer Drugs; 2013 Jun; 24(5):484-93. PubMed ID: 23466651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Demethylation of EHMT1/GLP Protein Reprograms Its Transcriptional Activity and Promotes Prostate Cancer Progression.
    Besschetnova A; Han W; Liu M; Gao Y; Li M; Wang Z; Labaf M; Patalano S; Venkataramani K; Muriph RE; Macoska JA; Siegfried KR; Evans J; Balk SP; Gao S; Han D; Cai C
    Cancer Res Commun; 2023 Aug; 3(8):1716-1730. PubMed ID: 37663929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The histone methyltransferase G9a: a new therapeutic target in biliary tract cancer.
    Mayr C; Helm K; Jakab M; Ritter M; Shrestha R; Makaju R; Wagner A; Pichler M; Beyreis M; Staettner S; Jaeger T; Klieser E; Kiesslich T; Neureiter D
    Hum Pathol; 2018 Feb; 72():117-126. PubMed ID: 29133140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylation of DNA Ligase 1 by G9a/GLP Recruits UHRF1 to Replicating DNA and Regulates DNA Methylation.
    Ferry L; Fournier A; Tsusaka T; Adelmant G; Shimazu T; Matano S; Kirsh O; Amouroux R; Dohmae N; Suzuki T; Filion GJ; Deng W; de Dieuleveult M; Fritsch L; Kudithipudi S; Jeltsch A; Leonhardt H; Hajkova P; Marto JA; Arita K; Shinkai Y; Defossez PA
    Mol Cell; 2017 Aug; 67(4):550-565.e5. PubMed ID: 28803780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel SAR for quinazoline inhibitors of EHMT1 and EHMT2.
    Leenders R; Zijlmans R; van Bree B; van de Sande M; Trivarelli F; Damen E; Wegert A; Müller D; Ehlert JE; Feger D; Heidemann-Dinger C; Kubbutat M; Schächtele C; Lenstra DC; Mecinović J; Müller G
    Bioorg Med Chem Lett; 2019 Sep; 29(17):2516-2524. PubMed ID: 31350126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting Epithelial-Mesenchymal Transition (EMT) to Overcome Drug Resistance in Cancer.
    Du B; Shim JS
    Molecules; 2016 Jul; 21(7):. PubMed ID: 27455225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EHMT2 is a metastasis regulator in breast cancer.
    Kim K; Son MY; Jung CR; Kim DS; Cho HS
    Biochem Biophys Res Commun; 2018 Feb; 496(2):758-762. PubMed ID: 29337058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.